Search research articles
Contact Us
Filters
Showing results (111-120 of 172) with videos related to
Page
of 18
Sort By:
Plos One
|
March 17, 2016
A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases
Bertrand Nalpas, Philippe Ichaï, Laure Jamot, et al.
Journal of Hepatology
|
August 10, 2013
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma
Marianne Ziol, Angela Sutton, Julien Calderaro, et al.
Human Vaccines & Immunotherapeutics
|
August 3, 2019
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial
Fabien Zoulim, Claire Fournier, François Habersetzer, et al.
International Journal of Molecular Sciences
|
October 23, 2021
Mass Spectrometry-Based Proteomics Reveal Alcohol Dehydrogenase 1B as a Blood Biomarker Candidate to Monitor Acetaminophen-Induced Liver Injury
Floriane Pailleux, Pauline Maes, Michel Jaquinod, et al.
Journal of Gastroenterology
|
May 18, 2013
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C
Jérôme Boursier, Victor de Ledinghen, Nathalie Sturm, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 5, 2026
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab
Erwan Vo-Quang, Claudia Campani, Manon Allaire, et al.
Kidney International
|
May 9, 2018
Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective
Laurent Alric, Isabelle Ollivier-Hourmand, Emilie Bérard, et al.
JHEP Reports : Innovation in Hepatology
|
August 5, 2024
Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide
Selma El Messaoudi, Ségolène Brichler, Claire Fougerou-Leurent, et al.
ESC Heart Failure
|
March 6, 2024
Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study
Amira Zaroui, Mounira Kharoubi, Romain Gounot, et al.
Clinics and Research in Hepatology and Gastroenterology
|
April 11, 2022
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response
Jessica Azzi, Céline Dorival, Carole Cagnot, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 172) with videos related to
Sort By:
Page
of 18
Plos One
|
March 17, 2016
A Proof of Concept, Phase II Randomized European Trial, on the Efficacy of ALF-5755, a Novel Extracellular Matrix-Targeted Antioxidant in Patients with Acute Liver Diseases
Bertrand Nalpas, Philippe Ichaï, Laure Jamot, et al.
Journal of Hepatology
|
August 10, 2013
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma
Marianne Ziol, Angela Sutton, Julien Calderaro, et al.
Human Vaccines & Immunotherapeutics
|
August 3, 2019
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial
Fabien Zoulim, Claire Fournier, François Habersetzer, et al.
International Journal of Molecular Sciences
|
October 23, 2021
Mass Spectrometry-Based Proteomics Reveal Alcohol Dehydrogenase 1B as a Blood Biomarker Candidate to Monitor Acetaminophen-Induced Liver Injury
Floriane Pailleux, Pauline Maes, Michel Jaquinod, et al.
Journal of Gastroenterology
|
May 18, 2013
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C
Jérôme Boursier, Victor de Ledinghen, Nathalie Sturm, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 5, 2026
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab
Erwan Vo-Quang, Claudia Campani, Manon Allaire, et al.
Kidney International
|
May 9, 2018
Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective
Laurent Alric, Isabelle Ollivier-Hourmand, Emilie Bérard, et al.
JHEP Reports : Innovation in Hepatology
|
August 5, 2024
Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide
Selma El Messaoudi, Ségolène Brichler, Claire Fougerou-Leurent, et al.
ESC Heart Failure
|
March 6, 2024
Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study
Amira Zaroui, Mounira Kharoubi, Romain Gounot, et al.
Clinics and Research in Hepatology and Gastroenterology
|
April 11, 2022
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response
Jessica Azzi, Céline Dorival, Carole Cagnot, et al.
Page
of 18